| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $248,653 | +9,713 | +59% | $25.60 | 26,120 | 26 Feb 2022 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $89,093 | -1,867 | -7.1% | $47.72 | 24,253 | 26 Feb 2022 | Direct | F2, F3 |
| transaction | PFE | Common Stock | Tax liability | $229,652 | -4,535 | -19% | $50.64 | 19,718 | 26 Feb 2022 | Direct | F4, F5 |
| transaction | PFE | Common Stock | Tax liability | $34,736 | -740 | -3.8% | $46.94 | 18,978 | 28 Feb 2022 | Direct | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -9,713 | -100% | $0.000000* | 0 | 26 Feb 2022 | Common Stock | 9,713 | $25.60 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | Price is the closing price of Pfizer common stock on February 25, 2022. |
| F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| F6 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |